+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Peptide Hormone"

Human Growth Hormone Market Report 2026 - Product Thumbnail Image

Human Growth Hormone Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biosimilar Growth Hormones Market Report 2026 - Product Thumbnail Image

Biosimilar Growth Hormones Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Synthetic Hormones Market Report 2026 - Product Thumbnail Image

Synthetic Hormones Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Prader Willi Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Prader Willi Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator

The Peptide Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Peptide hormones are a type of hormone that are composed of amino acids and are secreted by the endocrine glands. They are involved in a variety of physiological processes, including growth, metabolism, reproduction, and stress response. Peptide hormones are used to treat a variety of endocrine and metabolic disorders, such as diabetes, obesity, and hypothyroidism. They are also used to treat certain types of cancer, such as prostate cancer. Peptide hormones are typically administered via injection or inhalation. They are generally well-tolerated and have few side effects. However, they can be expensive and may require frequent dosing. Some companies in the Peptide Hormone market include Novo Nordisk, Eli Lilly, Sanofi, Merck, and Pfizer. Show Less Read more